David James Lennon Sells 9,689 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) Stock
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) CEO David James Lennon sold 9,689 shares of the stock in a transaction dated Thursday, October 3rd. The shares were sold at an average price of $1.94, for a total value of $18,796.66. Following the sale, the chief executive officer now owns 22,869 shares of the company’s […]
More Stories
Reece Limited (ASX:REH) Announces Dividend Increase – $0.18 Per Share
Reece Limited (ASX:REH – Get Free Report) announced a final dividend on Thursday, October 3rd, MarketIndexAU reports. Investors of record...
Visa Inc. (NYSE:V) Receives $310.22 Average PT from Brokerages
Visa Inc. (NYSE:V – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirty brokerages...
General Dynamics (NYSE:GD) PT Lowered to $314.00
General Dynamics (NYSE:GD – Get Free Report) had its target price decreased by Deutsche Bank Aktiengesellschaft from $320.00 to $314.00...
AngioDynamics (NASDAQ:ANGO) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS
AngioDynamics (NASDAQ:ANGO – Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported ($0.11) EPS...
Devon Energy (NYSE:DVN) PT Lowered to $50.00
Devon Energy (NYSE:DVN – Free Report) had its price objective reduced by Wells Fargo & Company from $55.00 to $50.00...
Amazon Hiring 250,000 Workers Ahead of Holiday Season
By Naveen Athrappully E-commerce firm Amazon is set to boost its workforce by a quarter million with the U.S. holiday...